Qimmune
qimmune.com
Actively hiring
Oncology Therapeutics
Biotechnology
Cell & Gene Therapy
Follow
Overview
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$25k
1 round on record
Latest round
$25k
Venture round · Sep 2026 · this month
The money's age
Fresh money
0 months since the last round · not hiring
Momentum
20/100
fresh money
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Tractionpublic signals, read monthly
Web presence
top 56%
of 133.2M domains by links, Common Crawl
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Sep 2026 | $25k | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | Q-Immune, Inc. | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
Cameron McCannExecutive Officer, DirectorSEC Form D
Stephen Paucha SmithExecutive Officer, DirectorSEC Form D
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Generate the optimized scFvs to yield CAR-T cells with robust anti-tumor effect.
Learn about Lyell and how we are building an industry-leading clinical-stage pipeline of CAR-T cell product candidates for cancer.
At Strike Pharma we are shaping a new era of immunotherapy by using our ADAC technology.
Autolus is a CAR T cell therapy company which develops advanced autologous T cell therapies that have the potential to deliver…
Umoja Biopharma pioneering immunotherapy by reprogramming T cells in vivo to target cancer cells and generate lasting remission.
Revolutionizing solid tumor treatment through AI-powered protein engineering. OUTSMART™, OUTLAST™, and OUTSPACER™ technologies enhance…
Overview
Q-Immune provides cutting-edge real-time protein network analysis for CAR-T cells, enabling accurate efficacy prediction, optimized CAR-T design, and improved immunotherapy outcomes to advance patient treatment strategies.
People
Cameron McCann
Executive Officer, Director
Stephen Paucha Smith
Executive Officer, Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Seattle
United States
HQ
Financials
Total raised
$25k
Latest round
Venture - Series Unknown
Funding rounds
1
Funding rounds
| Round | Announced | Amount | |
|---|---|---|---|
| Venture - Series Unknown | 2026 | $25k | Details |